Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.
Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group. Novi G, et al. Among authors: fenu g. Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4. Mult Scler Relat Disord. 2019. PMID: 31610404
The cohort of the multiple sclerosis center of Cagliari.
Marrosu MG, Lorefice L, Frau J, Coghe G, Fenu G, Piras R, Melis M, Cocco E. Marrosu MG, et al. Among authors: fenu g. Neurol Sci. 2011 Jan;31 Suppl 3:309-12. doi: 10.1007/s10072-010-0470-7. Neurol Sci. 2011. PMID: 21267619
Epidemiology of multiple sclerosis in south-western Sardinia.
Cocco E, Sardu C, Massa R, Mamusa E, Musu L, Ferrigno P, Melis M, Montomoli C, Ferretti V, Coghe G, Fenu G, Frau J, Lorefice L, Carboni N, Contu P, Marrosu MG. Cocco E, et al. Among authors: fenu g. Mult Scler. 2011 Nov;17(11):1282-9. doi: 10.1177/1352458511408754. Epub 2011 Jun 7. Mult Scler. 2011. PMID: 21652610
Monoclonal antibodies: a target therapy for multiple sclerosis.
Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG. Lorefice L, et al. Among authors: fenu g. Inflamm Allergy Drug Targets. 2014;13(2):134-43. doi: 10.2174/1871528113666140513114815. Inflamm Allergy Drug Targets. 2014. PMID: 24479836 Review.
Long-term benefits of induction therapy in NMO: a case report.
Frau J, Coghe G, Lorefice L, Fenu G, Cocco E. Frau J, et al. Among authors: fenu g. Neurol Sci. 2014 Nov;35(11):1831-2. doi: 10.1007/s10072-014-1830-5. Epub 2014 May 18. Neurol Sci. 2014. PMID: 24838612 No abstract available.
Influence of treatments in multiple sclerosis disability: a cohort study.
Cocco E, Sardu C, Spinicci G, Musu L, Massa R, Frau J, Lorefice L, Fenu G, Coghe G, Massole S, Maioli MA, Piras R, Melis M, Porcu G, Mamusa E, Carboni N, Contu P, Marrosu MG. Cocco E, et al. Among authors: fenu g. Mult Scler. 2015 Apr;21(4):433-41. doi: 10.1177/1352458514546788. Epub 2014 Sep 25. Mult Scler. 2015. PMID: 25257611
202 results